Your browser doesn't support javascript.
loading
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group.
Wagner, Anna Dorothea; Grabsch, Heike I; Mauer, Murielle; Marreaud, Sandrine; Caballero, Carmela; Thuss-Patience, Peter; Mueller, Lothar; Elme, Annelie; Moehler, Markus Hermann; Martens, Uwe; Kang, Yoon-Koo; Rha, Sun Young; Cats, Annemieke; Tokunaga, Masanori; Lordick, Florian.
Afiliación
  • Wagner AD; Department of Oncology, Lausanne University Hospital and University of Lausanne, Bugnon 46, 1011, Lausanne, Switzerland. dorothea.wagner@chuv.ch.
  • Grabsch HI; Department of Pathology and GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, Netherlands.
  • Mauer M; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
  • Marreaud S; EORTC Headquarters, Avenue E. Mounier 83, 1200, Bruxelles, Belgium.
  • Caballero C; EORTC Headquarters, Avenue E. Mounier 83, 1200, Bruxelles, Belgium.
  • Thuss-Patience P; EORTC Headquarters, Avenue E. Mounier 83, 1200, Bruxelles, Belgium.
  • Mueller L; Department of Hematology, Medical Oncology and Tumor Immunology, Augustenburger Platz 1, Charité Universitätsmedizin Berlin, 13353, Berlin, Germany.
  • Elme A; OnkologieUnterEms, 26789, Leer, Germany.
  • Moehler MH; North Estonian Regional Hospital Cancer Center, Hiiu 44, 11619, Tallinn, Estonia.
  • Martens U; University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
  • Kang YK; Department of Internal Medicine III, SLK-Kliniken Heilbronn GmbH, Am Gesundbrunnen 20-26, 74078, Heilbronn, Germany.
  • Rha SY; Department of Internal Medicine III, SLK-Kliniken Heilbronn GmbH, Am Gesundbrunnen 20-26, 74078, Heilbronn, Germany.
  • Cats A; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Tokunaga M; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Lordick F; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Plesmalaaan 121, 1066, Amsterdam, CX, Netherlands.
BMC Cancer ; 19(1): 494, 2019 May 24.
Article en En | MEDLINE | ID: mdl-31126258
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Unión Esofagogástrica / Anticuerpos Monoclonales Humanizados / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia / Europa Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Unión Esofagogástrica / Anticuerpos Monoclonales Humanizados / Trastuzumab / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia / Europa Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Suiza